High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: Case-control study

BMC Cancer

Volumn 9, Issue , 2009, Pages

  de León, David Cantú ^a   Pérez Montiel, Delia ^a   Villavicencio, Verónica ^a   Carranca, Alejandro Garcia ^b   Betancourt, Alejandro Mohar ^a   Acuña Alonzo, Victor ^c   López Tello, Alberto ^d   Vargas Alarcón, Gilberto ^e   Barquera, Rodrigo ^c   Yu, Neng ^f   Yunis, Edmond J ^g   Granados, Julio ^d  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE ANTROPOLOGÍA E HISTORIA   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^f AMERICAN RED CROSS BLOOD SERVICES   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HLA A ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA CW ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; HISPANIC; HLA TYPING; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; TUMOR IMMUNITY; ALLELE; BREAST TUMOR; GENETICS; HAPLOTYPE; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MIDDLE AGED;

EID: 79959340613     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-48     Document Type: Article

References (37)

1. McPherson K Steel CM Dixon JM ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics BMJ 2000, 321:624-8 1118507 10977847
2. Wall KM Núñez-Rocha GM Salinas-Martínez AM Sánchez-Peña SR Determinants of the use of breast cancer screening among women workers in urban Mexico Prev Chronic Dis 2008, 5:A50 2396987 18341785
3. Madigan MP Ziegler RG Benichou J Byrne C Hoover RN Proportion of breast cancer cases in the United States explained by well-established risk factors J Natl Cancer Inst 1995, 87:1681-5 7473816
4. Rodriguez-Cuevas S Macías CG Franceschi D Labastida S Breast carcinoma presents a decade earlier in mexican women than in women in the United States or european countries Cancer 2001, 91:863-8 11241256
5. Capote NL Epidemiología del cáncer de la glándula mamaria Avances en mastología Caracas, Venezuela Hernández MGA 2 1996:170-81
6. Parkin DM Muir CS Whealan Y Gao T Ferlay J Powell J Cancer incidence in five continents International Agency for Research on Cancer Scientific Publication Lyon, France 1992.
7. Surveillance Epidemiology and End Results http://seer.cancer.gov/manuals/ CD2.SEERDic.pdf
8. Shanahan F Pathogenesis of ulcerative colitis Lancet 1993, 342:407-11 8101906
9. Boon T Cerottini JC Eynde Van den B Bruggen van der P Van Pel A Tumor antigens recognized by T lymphocytes Annu Rev Immunol 1994, 12:337-65 8011285
10. Seung S Urban JL Schreiber H A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target J Exp Med 1993, 178:933-40 2191160 8394406
11. Boon T Cerottni JC Eynde Van den B Brugen Van den P Van Pel A Tumor antigens recognized by T lymphocytes Annu Rev Immunol 1994, 12:337-365 8011285
12. McMichael A A new look in tumor immunology Plainview, NY: Cold Spring Harbor Lab Press; 1992.
13. Chaudhuri S Cariappa A Tang M Bell D Haber DA Isselbacher KJ Finkelstein D Forcione D Pillai S Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may reprsent protective alleles PNAS 2000, 97:11451-54 17220 11027344
14. Holland JF Major histocompatibility complex antigens Cancer Medicine Williams and Wilkins. Philadelphia 1997:226
15. Birkby CA Curtis AS McGrath M Ripley BD MHC control of cell position in vitro J Cell Sci 1988, 89(Pt 2):167-74 3053739
16. Wintzer HO Benzing M von Kleist S Lacking prognostic significance of beta 2-microglobulin, MCH class I and class II antigen expression in breast carcinomas Br J Cancer 1990, 62:289-95 2201398
17. Klein T Levin I Niska A Koren R Gal R Schachter J Kfir B Narinski R Warchaizer S Klein B Correlation between tumor and serum beta 2 m expression in patients with breast cancer Eur J Immunogen 1996, 23:417-23 8971539
18. Garrido F Ruiz-Cabello F Cabrera T Perez-Villar JJ Lopez-Botet M Duggan-Keen M Stern PL Implications for immunesurveillance of altered HLA class I phenotypes in human tumors Immunol Today 1997, 18:89-95 9057360
19. Esteban F Concha A Huelin C Pérez-Ayala M Pedrinaci S Ruiz-Cabello F Garrido F Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx Int J Cancer 1989, 43:436-42 2647639
20. Ghosh AK Moore M Street AJ Howat JM Schofield PF Expression of HLA-D sub-region products on human colorectal carcinoma Int J Cancer 1986, 38:459-64 2428757
21. Gudmundsdóttir I Gunnlaugur Jónasson J Sigurdsson H Olafsdóttir K Tryggvadóttir L Ogmundsdóttir HM Altered expression of HLA class I antigens in breast cancer: Association with prognosis Int J Cancer 2000, 89(6):500-505 11102894
22. Cancer Prevention and Early Detection. Cancer Facts and Figures 2003 http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf
23. Davis RW Thomas M Cameron J St John TP Scherer S Padgett RA Rapid DNA isolations for enzymatic and hybridization analysis Methods Enzymol 1980, 65:404-411 6246361
24. Miller SA Dykes DD Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988, 16:1215 334765 3344216
25. Arlequin. ver. 2.000: A software for population genetics data analysis http://lgb.unige.ch/arlequin/
26. Popgene. Version 1.31 http://www.ualberta.ca/~fyeh/
27. Haldane JBS The estimation and significance of the logarithm of the ratio of frequencies Ann Hum Genet 1955, 20(4):309-311 13314400
28. Bland JM Altman DG Multiple significance tests: The Bonferroni method BMJ 1995, 21(6973):170 7833759 2548561
29. Svejgaard A Ryder LP HLA and disease associations: Detecting the strongest association Tissue Antigens 1994, 43:18-27 8023317
30. Han R Breitburd F Marche PN Orth G Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes Nature 1992, 356:66-8 1347151
31. Gaderi A Talei A Gharesi-Fard B Farjadian SH Amirzargar A Vasei M HLA-DBR1 alleles and the susceptibility of Iranian patients with breast cancer Pathol Oncol Res 2001, 7:39-41 11349219
32. Kleinberg L Flørenes VA Skrede M Dong HP Nielsen S McMaster MT Nesland JM Shih IeM Davidson B Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma Virchows Arch 2006, 449:31-9 16541284
33. Baccar Harrath A Yacoubi Loueslati B Troudi W Hmida S Sedkaoui S Dridi A Jridi A Ben Ayed F Ben Rhomdhane K Ben Ammar Elgaaied A HLA class II polymorphism: Protective or risk factors to breast cancer in Tunisia? Pathol Oncol Res 2006, 12:79-81 16799707
34. Lavado R Benavides M Villar E Ales I Alonso A Caballero A The HLA-B7 allele confers susceptibility to breast cancer in Spanish women Immunol Lett 2005, 101:223-5 16188571
35. Casoli C Zanelli P Adorni A Starcich BR Neri T Serological and molecular study on the HLA phenotype of female breast cancer patients Eur J Cancer 1994, 30A:1207-8 7654460
36. Gopalkrishnan L Patil S Chhaya S Badwe R Joshi N HLA alleles in pre-menopausal breast cancer patients from western India Indian J Med Res 2006, 124:305-12 17085834
37. Brunner CA Gokel JM Riethmüller Johnson JP Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis Eur J Cancer 1991, 27:411-6 1828168